This website or its third-party tools process personal data. You can opt out of the sale of your personal information by clicking on the “Do Not Sell or Share My Personal Information” link.
Powered by
Opt-out Preferences
We use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. However, you can opt out of these cookies by checking "Do Not Sell or Share My Personal Information" and clicking the "Save My Preferences" button. Once you opt out, you can opt in again at any time by unchecking "Do Not Sell or Share My Personal Information" and clicking the "Save My Preferences" button.
Stendra, manufactured by Metuchen Pharmaceuticals LLC, is an FDA-approved medication for erectile dysfunction. It works quickly to enhance blood flow and achieve an erection, offering a convenient option with a favorable safety profile for men seeking treatment.
Stendra is an oral prescription PDE-5 inhibitor with moderate side effects, potential cardiovascular risks, and drug interactions. It requires medical oversight for special populations and periodic monitoring, but has straightforward dosing, low misuse potential, and easy adherence with as-needed use.
ACNU Feasibility Scorecard
Chart with 11 data points.
Stendra
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying ← Lower is Better!. Data ranges from 1 to 6.
Safety & Risk ProfileSeverity of Side EffectsOverdose PotentialRisk of MisuseDrug-Drug InteractionsSpecial ConsiderationsUsability DifficultyDosing ComplexityMonitoring RequirementsAdherence DifficultyPotential for Tolerance